Doubling Time of Soluble CD23: A Powerful Prognostic Factor for Newly Diagnosed and Untreated Stage a Chronic Lymphocytic Leukemia Patients

Leukemia - United Kingdom
doi 10.1038/leu.2008.190
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Acute Promyelocytic Leukemia and Chronic Lymphocytic Leukemia Diagnosed Concurrently

American Journal of Hematology
Hematology
2017English

Externally Validated Predictive Clinical Model for Untreated Del(17p13.1) Chronic Lymphocytic Leukemia Patients

American Journal of Hematology
Hematology
2015English

Profile of Obinutuzumab for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia

OncoTargets and Therapy
OncologyPharmacology
2015English

Chemoimmunotherapy May Overcome the Adverse Prognostic Significance of 11q Deletion in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Cancer
Cancer ResearchOncology
2008English

Albumin-To-Fibrinogen Ratio as an Independent Prognostic Parameter in Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of 191 Cases

Cancer Research and Treatment
Cancer ResearchOncology
2019English

A Molecular Score by Quantitative PCR as a New Prognostic Tool at Diagnosis for Chronic Lymphocytic Leukemia Patients

PLoS ONE
Multidisciplinary
2010English

Evaluation of Periodontal Parameters in Patients With Early Stage Chronic Lymphocytic Leukemia

Acta Stomatologica Croatica
Dentistry
2016English

Chronic Lymphocytic Leukemia and Prognostic Models: A Bridge Between Clinical and Biological Markers

American Journal of Hematology
Hematology
2017English

Humoral Immune Responses Toward Tumor-Derived Antigens in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy